ADELAIDA MAYETA-PEART: Open Payments
NPI 1881211233 · CONYERS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,430 in 74 payments from 18 companies in 2025. Trend: 2023 $220 · 2024 $1,052 · 2025 $1,430
Food & beverage: $1,430
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $239 |
| AstraZeneca Pharmaceuticals LP | 12 | $238 |
| Lilly USA, LLC | 9 | $146 |
| SANOFI-AVENTIS U.S. LLC | 5 | $104 |
| Novo Nordisk Inc | 5 | $99 |
| PFIZER INC. | 5 | $99 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $75 |
| ABBVIE INC. | 3 | $65 |
| SHIELD THERAPEUTICS INC | 3 | $63 |
| Boston Scientific Corporation | 2 | $57 |
Products named: KRYSTEXXA, OTEZLA, TZIELD, MOUNJARO, BREZTRI, Wegovy, FARXIGA, Kerendia.
Industry payments across GA — which companies pay providers there.
